Medtronic Says Edurant 'AAA' Stent Graft Demonstrates Sustained Durability in Complex Patients

Presented to endovascular specialists at the 35^th Charing Cross International Symposium in London, a new analysis of clinical data on the Endurant AAA Stent Graft System from Medtronic, Inc. (NYSE: MDT ) demonstrates the implanted medical device's consistent and compelling performance in treating abdominal aortic aneurysms across a range of patient anatomies, from relatively